Wafra Inc’s Halozyme HALO Stock Holding History

Wafra Inc’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-53,877	Closed	-$2.19M	–	23
2024 Q1	$2.19M	Hold	53,877	–	–	0.12%	63
2023 Q4	$1.99M	Buy	53,877 +23,811	+79%	+$897K	0.12%	63
2023 Q3	$1.15M	Buy	+30,066	New	+$1.23M	0.04%	64

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Wafra Inc's HALO Position: Q2 2024 in Review

Wafra Inc sold out of Halozyme (HALO) in Q2 2024, closing a stake of 53,877 shares — an estimated $2.19M sold.

Wafra Inc first reported a position in HALO in Q3 2023 and held it in 3 quarters. The position peaked at $2.19M in Q1 2024. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

Wafra Inc reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
Wafra Inc sold 53,877 Halozyme shares in Q2 2024, an estimated $2.19M.
Wafra Inc first reported a position in Halozyme in Q3 2023 and held it in 3 quarters.
Wafra Inc's Halozyme position peaked at $2.19M in Q1 2024.
460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on Wafra Inc's 13F filing for Q2 2024, filed 5 Aug 2024.